- Home
- YMAB vs FOF Comparison
YMAB vs FOF Comparison
Compare YMAB & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- FOF
- Stock Information
- Founded
- YMAB 2015
- FOF 2006
- Country
- YMAB United States
- FOF United States
- Employees
- YMAB N/A
- FOF N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- FOF Investment Managers
- Sector
- YMAB Health Care
- FOF Finance
- Exchange
- YMAB Nasdaq
- FOF Nasdaq
- Market Cap
- YMAB 386.7M
- FOF 354.8M
- IPO Year
- YMAB 2018
- FOF N/A
- Fundamental
- Price
- YMAB $8.61
- FOF $12.83
- Analyst Decision
- YMAB Buy
- FOF
- Analyst Count
- YMAB 10
- FOF 0
- Target Price
- YMAB $13.91
- FOF N/A
- AVG Volume (30 Days)
- YMAB 874.6K
- FOF 58.7K
- Earning Date
- YMAB 11-07-2025
- FOF 01-01-0001
- Dividend Yield
- YMAB N/A
- FOF 9.07%
- EPS Growth
- YMAB N/A
- FOF N/A
- EPS
- YMAB N/A
- FOF N/A
- Revenue
- YMAB $85,385,000.00
- FOF N/A
- Revenue This Year
- YMAB N/A
- FOF N/A
- Revenue Next Year
- YMAB $13.97
- FOF N/A
- P/E Ratio
- YMAB N/A
- FOF N/A
- Revenue Growth
- YMAB N/A
- FOF N/A
- 52 Week Low
- YMAB $3.55
- FOF $9.59
- 52 Week High
- YMAB $16.11
- FOF $11.75
- Technical
- Relative Strength Index (RSI)
- YMAB 81.21
- FOF 37.05
- Support Level
- YMAB $8.50
- FOF $13.00
- Resistance Level
- YMAB $8.56
- FOF $13.12
- Average True Range (ATR)
- YMAB 0.02
- FOF 0.10
- MACD
- YMAB -0.12
- FOF -0.03
- Stochastic Oscillator
- YMAB 100.00
- FOF 9.66
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.